We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultraviolet-C Effectiveness in the Management of Pressure Ulcers in People With Spinal Cord Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01500174
Recruitment Status : Completed
First Posted : December 28, 2011
Last Update Posted : September 5, 2012
Sponsor:
Collaborator:
Ontario Neurotrauma Foundation
Information provided by (Responsible Party):
Ethne L Nussbaum, Toronto Rehabilitation Institute

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

The objective of the study is to examine the effectiveness of Ultraviolet-C (UVC) for healing pressure ulcers in people with spinal cord injury. UVC is a form of radiation similar to sunlight but it is normally absorbed in the earth's atmosphere. Participants will be assigned by chance to receive placebo-UVC or real UVC treatment, in addition to receiving wound care according to best practice guidelines. The hypothesis is that UVC-treated wounds will heal at a faster rate than wounds receiving placebo treatment.

Given that pressure ulcers impact on an individual's quality of life, and generate high costs to the overall health care system, further work is needed to explore alternative means of pressure ulcer treatment.


Condition or disease Intervention/treatment Phase
Pressure Ulcer Device: ultraviolet therapy UV254 Device: Placebo ultraviolet therapy UV254 Not Applicable

Detailed Description:
UVC or placebo UVC will be applied to wounds three times per week. Intact skin around the wound edge and the wound base will be irradiated.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 43 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Ultraviolet-C Irradiation in the Management of Pressure Ulcers in People With Spinal Cord Injury: A Randomized, Stratified, Placebo-controlled Trial
Study Start Date : November 2007
Actual Primary Completion Date : May 2010
Actual Study Completion Date : May 2011

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: active UVC device
Three times per week irradiation of wound base and periwound skin
 Device: ultraviolet therapy UV254
three times per week until wound closure or patient discharge from hospital
Placebo Comparator: Placebo UVC device
Three times per week irradiation of wound base and periwound skin
 Device: Placebo ultraviolet therapy UV254
Three times per week irradiation of wound base and periwound skin


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Change in ulcer area relative to baseline [ Time Frame: At baseline and repeated weekly up to wound closure or duration of hospital stay to a maximum of 32 weeks ]
    Wounds are photographed at baseline and measurement is repeated every week either until the wound is closed or the subject is discharged from hospital, up to a maximum of 32 weeks. A metric reference is fixed to skin adjacent to the wound. A blinded assessor measures area directly from the number-coded images using digital software. Percent change is calculated each week relative to baseline.


Secondary Outcome Measures :
  1. Mean change in ulcer area between consecutive weeks [ Time Frame: At baseline and repeated weekly up to wound closure or duration of hospital stay up to a maximum of 32 weeks ]
    Wounds are photographed at baseline and measurement is repeated every week either until the wound is closed or the subject is discharged from hospital, up to a maximum of 32 weeks. A metric reference is fixed to skin adjacent to the wound. A blinded assessor measures area directly from the number-coded images using digital software. Percent change in area relative to the previous measurement is calculated each week for the individual and then averaged for the individual over all weeks of the study.

  2. Change in Photographic Wound Assessment Tool (PWAT) [ Time Frame: From baseline to wound closure or when the subject is discharged from hospital ]
    The PWAT characterizes six aspects of wound appearance (wound edge, necrotic tissue type and amount, skin colour, granulation tissue and epithelialization), and yields scores ranging from 0-24, where higher scores indicate more severe wounds. A blinded assessor scored the PWAT using the number-coded images.

  3. Change in Cardiff Wound Impact Schedule (CWIS) [ Time Frame: From baseline to wound closure or when subject is discharged from hospital ]
    The CWIS is a condition-specific quality of life (QOL) tool that evaluates wound impact on four domains: overall QOL, well-being, physical experience and the perceived stress of the physical experience.

  4. Follow-up wound status [ Time Frame: At 1, 6 and 12 months post-intervention ]
    Telephone interview - subjects were asked about status of study wounds - open or closed


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • traumatic, non-traumatic or congenital spinal cord injury C2-L2
  • pressure ulcer stage 2 or higher

Exclusion Criteria:

  • neoplastic wound
  • wound surgically repaired within past 3 months
  • wound currently treated with negative pressure therapy
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01500174


Locations
Layout table for location information
Canada, Ontario
Toronto Rehabilitation Institute
Toronto, Ontario, Canada, M4G 3V9
Sponsors and Collaborators
Toronto Rehabilitation Institute
Ontario Neurotrauma Foundation
Investigators
Layout table for investigator information
Principal Investigator: Ethne L Nussbaum, PhD Toronto Rehabilitation Institute
Principal Investigator: Colleen F McGillivray, MD, FRCPC Toronto Rehabilitation Institute
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Ethne L Nussbaum, Principle Investigator, Toronto Rehabilitation Institute
ClinicalTrials.gov Identifier: NCT01500174    
Other Study ID Numbers: SCI-2007-BDRST-465
First Posted: December 28, 2011    Key Record Dates
Last Update Posted: September 5, 2012
Last Verified: September 2012
Keywords provided by Ethne L Nussbaum, Toronto Rehabilitation Institute:
skin
decubitus
pressure
sore
spinal cord injury
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Pressure Ulcer
Ulcer
Pathologic Processes
Spinal Cord Diseases
Central Nervous System Diseases
 Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Skin Ulcer
Skin Diseases